Acid-Suppressive Effect of Rabeprazole 5 mg and 10 mg Once Daily by 24-Hour Esophageal pH Monitoring in Patients with Non-erosive Reflux Disease in Japan: A Multicenter, Randomized, Parallel-Group, Double-Blind Pharmacodynamic Study

Author： Ashida Kiyoshi  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.56, Iss.8, 2011-08, pp. : 2333-2342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan

By Kinoshita Yoshikazu   Kobayashi Takeaki   Kato Mototsugu   Asahina Kan   Haruma Ken   Shimatani Tomohiko   Inoue Shuji   Kabemura Teppei   Kurosawa Susumu   Kuwayama Hajime   Ashida Kiyoshi   Hirayama Michiaki   Kiyama Satoshi   Yamamoto Munemitsu   Suzuki Junichi   Suzuki Hiroyuki   Matsumoto Katsuhiko   Aoshima Masaru  

Journal of Gastroenterology, Vol. 41, Iss. 6, 2006-06 ,pp. : 554-561

Springer Publishing Company

Access to resources Recommend Favorite

Acid-Suppressive Efficacy of a Reduced Dosage of Rabeprazole: Comparison of 10 Mg Twice Daily Rabeprazole with 20 Mg Twice Daily Rabeprazole, 30 Mg Twice Daily Lansoprazole, and 20 Mg Twice Daily Omeprazole by 24-Hr Intragastric pH-metry

By Shimatani Tomohiko   Inoue Masaki   Kuroiwa Tomoko   Xu Jing   Tazuma Susumu   Horikawa Yoko   Nakamura Masuo  

Digestive Diseases and Sciences, Vol. 50, Iss. 7, 2005-07 ,pp. : 1202-1206

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Proton Pump Inhibitor-Resistant Nonerosive Reflux Disease by Esophageal Manometry and 24-Hour Esophageal Impedance and pH Monitoring

By  

Digestion, Vol. 91, Iss. 1, 2015-01 ,pp. : 19-25

Karger

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 5, 2009-04 ,pp. : 509-518

Karger

Access to resources Recommend Favorite

Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection

By  

Digestion, Vol. 95, Iss. 2, 2017-02 ,pp. : 140-145

Karger

Access to resources Recommend Favorite